x

Posted 02 February, 2021

Ventas, Inc. appointed new CEO

CEO Change detected for ticker NYSE:VTR in a 8-K filed on 02 February, 2021.


  Effective February 1, 2021, Maurice Smith, President and Chief Executive Officer of Health Care Service Corporation, was appointed as an independent director to the Board of Directors of the Company.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Ventas, Inc.
Real Estate/Construction • Healthcare REITs
Ventas, Inc. engages in the acquisition and ownership of seniors housing and healthcare properties. It operates through the following segments: Senior Housing Operating Portfolio (SHOP), Outpatient Medical and Research Portfolio (OM&R), and Triple-net Leased Properties (NNN). The SHOP segment is involved in owning and investing in senior housing communities throughout the United States and Canada. The OM&R segment refers to acquiring, owning, development, leasing and managing outpatient medical buildings and research centers throughout the United States. The NNN segment focuses on investing and owning senior housing communities, skilled nursing facilities, long-term acute care facilities, freestanding inpatient rehabilitation facilities, and other healthcare facilities throughout the United States and the United Kingdom. The company was founded in 1983 and is headquartered in Chicago, IL.
Market Cap
$31.6B
View Company Details
Ventas, Inc. by TradingView
Relevant filing section
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 


Effective February 1, 2021, Maurice Smith, President and Chief Executive Officer of Health Care Service Corporation, was appointed as an independent director to the Board of Directors of the Company. 


Mr. Smith is not a party to any transaction with the Company that would require disclosure under Item 404(a) of Regulation S-K, and there are no arrangements or understandings between Mr. Smith and any other persons pursuant to which he was selected as a director. As of the time of the filing of this Current Report on Form 8-K, the Board of Directors has not determined the committees, if any, to which Mr. Smith may be appointed. Mr. Smith will participate in the compensation arrangements for non-employee directors, including receiving an initial award of shares of restricted stock upon appointment, as described in the Company's 2020 Proxy Statement filed with the Securities & Exchange Commission on April 8, 2020.


A copy of the press release issued by the Company on February 2, 2021, announcing the appointment of Mr. Smith to the Board of Directors, is attached to this Current Report on Form 8-K as Exhibit 99.1.